Jobs / United States / Astrazeneca Pharmaceuticals Lp
Global Clinical Head- Executive Director
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Global Product Teams Finance Director, R&D Finance” (Financial Managers) in MD: $196k–$196k, median $196k. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Job Description: Global Clinical Head- Executive Director Infectious Disease Are you a clinical research expert ready for new opportunities? Would you like to play a pivotal role in the development of potential medicines? If you are passionate about being a medical leader for a cross-functional team in a group that drives action towards the improvement of global public health– join us! As Global Clinical Head you will have a unique opportunity to further elevate the Infectious Disease Therapy Area in one of the world’s most respected biopharmaceutical companies. The role holds a significant development opportunity for the successful candidate whilst contributing to the positive journey that AstraZeneca is on. Accountabilities: The Global Clinical Head (GCH) will have overall clinical leadership of one or more global products in the Infectious Disease pipeline. The GCH is also responsible for medical/scientific strategies for the clinical components of the Target Product Profile (TPP), Clinical Development Plan (CDP), and regulatory documents (e.g., briefing documents, CTD/BLA, core labelling texts). Within the Clinical Project Team, the GCH has accountability for the clinical, scientific, and value content and delivery of the medical components for the program to time and quality. The GCH will be the team’s voice and representative on the Global Project Team that oversees the overall strategy of Infection products. Essential Skills/Experience: • Graduate of a recognized school of medicine with an MD degree or equivalent • Demonstrated clinical research expertise in Infectious Diseases and vaccines • At least 10 years of pharmaceutical industry knowledge and experience • Experience in early and late stage program development and trial conduct • Demonstrated ability to lead the development of a program strategy and be accountable for project plans, timelines, progress, and outcomes • Global regulatory submissions, interacting with major Health Authorities, and experience with regulatory document writing and filings (e.g., NDA/BLA submissions, benefit/risk assessment) • Demonstrated ability leading and motivating teams in a matrix environment • Demonstrated ability to lead, coach, and mentor physicians and clinical scientists • Significant hands-on clinical drug development experience and scientific credibility • Developed/delivered in parallel, composed of multiple complex and large studies (e.g., including but not limited to multinational, pivotal Phase 3 efficacy studies) • Clinical experience as a practicing physician in the hospital and/or clinic setting • Demonstrated ability to cultivate excellent cross-functional collaborations • Demonstrated ability to effectively communicate at multiple levels of the organization with excellent verbal and written communication skills (including giving presentations) in English • Must demonstrate high integrity • Organize and deliver Advisory Boards with international Key External Experts • Demonstrated AI/digital mindset and experience applying AI-enabled and generative AI tools to support clinical development activities (e.g., data analysis, medical writing, clinical trial operational efficiency) • Be office based at the Gaithersburg AstraZeneca site at least 3 days a week Desirable Skills/Experience : • Named Investigator on a number of clinical trials • Regulatory affairs expertise with a major health authority • Progressed compounds into first time in human Phase 1 studies and Phase 2 delivery of proof of principle studies • Significant and consistent peer-reviewed publication track record When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at